Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Wullich

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 11, 2012
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jawPhilipp Stockmann, Emeka Nkenke, Matthias Englbrecht, et al.
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
International Journal of Cancer|September 30, 2010
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinomaBastian Keck, Robert Stoehr, Sven Wach, et al.
Plos One|October 30, 2013
Collecting duct carcinomas represent a unique tumor entity based on genetic alterationsFrank Becker, Kerstin Junker, Martin Parr, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
BMC Nephrology|October 4, 2013
BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibitionJohannes Jacobi, Antonina Prignitz, Maike Büttner, et al.
Urologic Oncology|July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancerDanijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
International Journal of Cancer|March 29, 2014
High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patientsAstrid Kehlen, Thomas Greither, Sven Wach, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 11, 2012
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jawPhilipp Stockmann, Emeka Nkenke, Matthias Englbrecht, et al.
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
International Journal of Cancer|September 30, 2010
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinomaBastian Keck, Robert Stoehr, Sven Wach, et al.
Plos One|October 30, 2013
Collecting duct carcinomas represent a unique tumor entity based on genetic alterationsFrank Becker, Kerstin Junker, Martin Parr, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
BMC Nephrology|October 4, 2013
BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibitionJohannes Jacobi, Antonina Prignitz, Maike Büttner, et al.
Urologic Oncology|July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancerDanijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
International Journal of Cancer|March 29, 2014
High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patientsAstrid Kehlen, Thomas Greither, Sven Wach, et al.
Pageof 26